Culebras Diego, Pedrosa Leire, Mosteiro Alejandra, Llull Laura, Topczewski Thomaz, Zattera Luigi, Díez-Salvatierra Laura, Dolz Guillem, Amaro Sergi, Torné Ramon
Department of Neurosurgery, Hospital Clinic of Barcelona, Barcelona, Spain.
Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Front Neurol. 2025 Apr 2;16:1536643. doi: 10.3389/fneur.2025.1536643. eCollection 2025.
Aneurysmal subarachnoid hemorrhage (aSAH) is a rare cause of stroke that poses significant morbidity and mortality, as it affects patients around the age of 50 years. While advances in early aneurysm intervention have reduced mortality rates, many patients still experience poor outcomes due to early brain injury (EBI) and delayed cerebral ischemia (DCI). This study aims to explore the characteristics of patients with poor neurological outcomes among patients with poor neurological status at admission, using comprehensive clinical and neuroimaging data.
We analyzed 377 aSAH patients (WFNS 4-5) admitted between 2013 and 2020, focusing on demographics, clinical assessments, imaging, treatments, and outcomes at discharge and 3 months later.
Among the cohort, which predominantly consisted of females, the mortality rate was 49%. Our findings indicate that older patients had poorer functional outcomes; notably, 59% of patients aged 75 and older had limitations on therapeutic efforts, leading to a 100% mortality rate in that subgroup. There was no difference in outcomes between endovascular and surgical treatments. However, patients undergoing multimodal monitoring had better functional outcomes at discharge. Angiographic vasospasm was found in 31% of patients and was linked to poorer outcomes at discharge ( = 0.016). Though DCI did not directly correlate with functional outcomes, it correlated strongly with new cerebral infarcts (90% incidence).
The prognosis of patients with aSAH and poor neurological status on admission is generally poor. Multimodal monitoring and tailored treatment appear to be beneficial in achieving favorable results in these patients. Despite the initial severity, up to 20% of patients achieve a good functional result on discharge and up to 35% do so at 3 months. These should be considered in the initial prognostic assessment with the families of these patients.
动脉瘤性蛛网膜下腔出血(aSAH)是一种罕见的中风病因,会导致严重的发病率和死亡率,因为它主要影响50岁左右的患者。虽然早期动脉瘤干预的进展降低了死亡率,但许多患者仍因早期脑损伤(EBI)和迟发性脑缺血(DCI)而预后不良。本研究旨在利用综合临床和神经影像数据,探讨入院时神经功能状态不佳的患者中神经功能预后不良的患者特征。
我们分析了2013年至2020年间收治的377例aSAH患者(世界神经外科联盟分级4 - 5级),重点关注人口统计学、临床评估、影像学、治疗方法以及出院时和3个月后的预后情况。
在这个以女性为主的队列中,死亡率为49%。我们的研究结果表明,老年患者的功能预后较差;值得注意的是,75岁及以上的患者中有59%在治疗方面存在限制,导致该亚组的死亡率为100%。血管内治疗和手术治疗的预后没有差异。然而,接受多模式监测的患者出院时功能预后更好。31%的患者发现有血管造影血管痉挛,且与出院时较差的预后相关(P = 0.016)。虽然DCI与功能预后没有直接相关性,但它与新的脑梗死密切相关(发生率90%)。
入院时神经功能状态不佳的aSAH患者预后通常较差。多模式监测和个性化治疗似乎有利于这些患者取得良好的治疗效果。尽管初始病情严重,但高达20%的患者出院时功能恢复良好,3个月时这一比例高达35%。在对这些患者的家属进行初始预后评估时应考虑到这些情况。